The goals of the CAPRELSA REMS Program are to mitigate the serious risks of QT prolongation, Torsades de pointes, and sudden death associated with use of CAPRELSA by:

- Educating prescribers on the following:

  ° Serious risks of QT prolongation, Torsades de pointes, and sudden death associated with use of CAPRELSA.

  ° The need to monitor for QT prolongation and electrolyte abnormalities.

  ° Appropriate management of QT prolongation to minimize the occurrence of Torsades de pointes and sudden death associated with use of CAPRELSA.

- Informing patients on the following:

° Serious risks of QT prolongation, Torsades de pointes, and sudden death associated with use of CAPRELSA